Stealth BioTherapeutics (Stealth BioTherapeutics) Interest Expense : $-1.48 Mil (TTM As of Mar. 2022)

View and export this data going back to 2019. Start your Free Trial

What is Stealth BioTherapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Stealth BioTherapeutics's interest expense for the three months ended in Mar. 2022 was $ -0.54 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2022 was $-1.48 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Stealth BioTherapeutics's Operating Income for the three months ended in Mar. 2022 was $ -13.07 Mil. Stealth BioTherapeutics's Interest Expense for the three months ended in Mar. 2022 was $ -0.54 Mil. Stealth BioTherapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Stealth BioTherapeutics Interest Expense Historical Data

The historical data trend for Stealth BioTherapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stealth BioTherapeutics Interest Expense Chart

Stealth BioTherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Interest Expense

Get a 7-Day Free Trial

-3.28

-21.36

-6.67

-1.81

-1.24

Stealth BioTherapeutics Quarterly Data
	Dec16	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22
Interest Expense	Get a 7-Day Free Trial															-0.30	-0.19	-0.20	-0.56	-0.54

Stealth BioTherapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.48 Mil.

Stealth BioTherapeutics (NAS:MITO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Stealth BioTherapeutics's Interest Expense for the three months ended in Mar. 2022 was $-0.54 Mil. Its Operating Income for the three months ended in Mar. 2022 was $-13.07 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2022 was $13.78 Mil.

Stealth BioTherapeutics's Interest Coverage for the quarter that ended in Mar. 2022 is calculated as

Stealth BioTherapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Stealth BioTherapeutics (Stealth BioTherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stealth BioTherapeutics Corp (NAS:MITO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Intertrust Corporate Services (Cayman) Limited, One Nexus way, Camana Bay, Grand Cayman, CYM, KY1-9005

Website

https://www.stealthbt.com

Stealth BioTherapeutics Corp is a clinical-stage biotechnology company. It is focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction.